Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease.
Saved in:
| Title: | Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. |
|---|---|
| Authors: | Kielbasa W; Eli Lilly and Company Indianapolis Indiana USA., Goldsmith P; Eli Lilly and Company Indianapolis Indiana USA., Donnelly KB; Eli Lilly and Company Indianapolis Indiana USA., Nuthall HN; Eli Lilly and Company Indianapolis Indiana USA., Shcherbinin S; Eli Lilly and Company Indianapolis Indiana USA., Fleisher AS; Eli Lilly and Company Indianapolis Indiana USA., Hendle J; Eli Lilly and Company Indianapolis Indiana USA., DuBois SL; Eli Lilly and Company Indianapolis Indiana USA., Lowe SL; Eli Lilly and Company Indianapolis Indiana USA., Zhang FF; Eli Lilly and Company Indianapolis Indiana USA., Woerly EM; Eli Lilly and Company Indianapolis Indiana USA., Dreyfus NJ; Eli Lilly and Company Indianapolis Indiana USA., Evans D; Eli Lilly and Company Indianapolis Indiana USA., Gilmore J; Eli Lilly and Company Indianapolis Indiana USA., Mancini M; Eli Lilly and Company Indianapolis Indiana USA., Constantinescu CC; Invicro LLC Boston Massachusetts USA., Gunn RN; Invicro London UK., Russell DS; Invicro LLC Boston Massachusetts USA., Collins EC; Eli Lilly and Company Indianapolis Indiana USA., Brys M; Eli Lilly and Company Indianapolis Indiana USA., Hutton ML; Eli Lilly and Company Indianapolis Indiana USA., Mergott DJ; Eli Lilly and Company Indianapolis Indiana USA. |
| Source: | Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2024 Dec 26; Vol. 10 (4), pp. e70020. Date of Electronic Publication: 2024 Dec 26 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39748851 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kielbasa+W%22">Kielbasa W</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Goldsmith+P%22">Goldsmith P</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Donnelly+KB%22">Donnelly KB</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Nuthall+HN%22">Nuthall HN</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Shcherbinin+S%22">Shcherbinin S</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Fleisher+AS%22">Fleisher AS</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Hendle+J%22">Hendle J</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22DuBois+SL%22">DuBois SL</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Lowe+SL%22">Lowe SL</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Zhang+FF%22">Zhang FF</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Woerly+EM%22">Woerly EM</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Dreyfus+NJ%22">Dreyfus NJ</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Evans+D%22">Evans D</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Gilmore+J%22">Gilmore J</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Mancini+M%22">Mancini M</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Constantinescu+CC%22">Constantinescu CC</searchLink>; Invicro LLC Boston Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Gunn+RN%22">Gunn RN</searchLink>; Invicro London UK.<br /><searchLink fieldCode="AU" term="%22Russell+DS%22">Russell DS</searchLink>; Invicro LLC Boston Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Collins+EC%22">Collins EC</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Brys+M%22">Brys M</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Hutton+ML%22">Hutton ML</searchLink>; Eli Lilly and Company Indianapolis Indiana USA.<br /><searchLink fieldCode="AU" term="%22Mergott+DJ%22">Mergott DJ</searchLink>; Eli Lilly and Company Indianapolis Indiana USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101650118%22">Alzheimer's & dementia (New York, N. Y.)</searchLink> [Alzheimers Dement (N Y)] 2024 Dec 26; Vol. 10 (4), pp. e70020. <i>Date of Electronic Publication: </i>2024 Dec 26 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+on+behalf+of+the+Alzheimer's+Association%22">Wiley on behalf of the Alzheimer's Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101650118 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-8737 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223528737%22">23528737 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement (N Y) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39748851 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/trc2.70020 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70020 Titles: – TitleFull: Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kielbasa W – PersonEntity: Name: NameFull: Goldsmith P – PersonEntity: Name: NameFull: Donnelly KB – PersonEntity: Name: NameFull: Nuthall HN – PersonEntity: Name: NameFull: Shcherbinin S – PersonEntity: Name: NameFull: Fleisher AS – PersonEntity: Name: NameFull: Hendle J – PersonEntity: Name: NameFull: DuBois SL – PersonEntity: Name: NameFull: Lowe SL – PersonEntity: Name: NameFull: Zhang FF – PersonEntity: Name: NameFull: Woerly EM – PersonEntity: Name: NameFull: Dreyfus NJ – PersonEntity: Name: NameFull: Evans D – PersonEntity: Name: NameFull: Gilmore J – PersonEntity: Name: NameFull: Mancini M – PersonEntity: Name: NameFull: Constantinescu CC – PersonEntity: Name: NameFull: Gunn RN – PersonEntity: Name: NameFull: Russell DS – PersonEntity: Name: NameFull: Collins EC – PersonEntity: Name: NameFull: Brys M – PersonEntity: Name: NameFull: Hutton ML – PersonEntity: Name: NameFull: Mergott DJ IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 12 Text: 2024 Dec 26 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2352-8737 Numbering: – Type: volume Value: 10 – Type: issue Value: 4 Titles: – TitleFull: Alzheimer's & dementia (New York, N. Y.) Type: main |
| ResultId | 1 |